V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290006935 | 290005270 | null | null | Disease modification (D) | 2016-03-26 | 2016-04-04 | Trastuzumab 21 day maintenance | N | N | 290021398 | LANREOTIDE |
| 290006936 | 290005271 | 1.51 | 66.6 | Palliative (P) | 2016-09-20 | 2016-09-20 | CAPECITABINE + RT | 02 | N | 290021403 | SUNITINIB |
| 290006937 | 290005271 | 1.63 | null | Curative (C) | 2016-11-24 | 2017-01-10 | Trial Unspecified | null | N | 290021403 | MITOMYCIN |
| 290006938 | 290005272 | 1.79 | 74.2 | null | 2017-11-07 | 2017-11-19 | CETUXIMAB | 02 | N | 290021413 | CAPECITABINE |
| 290006939 | 290007230 | 1.7 | 63 | null | 2018-05-11 | 2018-05-11 | INTERAACT trial | N | N | 290021416 | CAPECITABINE |
| 290006940 | 290005273 | null | null | null | 2013-08-09 | 2013-08-15 | Capecitabine 35days + RT | N | N | 290021421 | LANREOTIDE |
| 290006941 | 290005274 | 1.6 | null | Palliative (P) | 2015-01-04 | 2015-02-26 | Carboplatin AUC 6 - 10 | N | N | 290021425 | DOXORUBICIN EMBOLISATION |
| 290006942 | 290005276 | 1.84 | 99.4 | Palliative (P) | 2014-04-28 | 2014-04-28 | CARBOPLATIN + RT | Y | N | 290021430 | CARBOPLATIN + PEMETREXED |
| 290006943 | 290005277 | 1.71 | 80.8 | Palliative (P) | 2014-02-09 | 2014-02-09 | Capecitabine + Oxaliplatin 21day | 02 | N | 290021435 | LANREOTIDE |
| 290006944 | 290005278 | 1.79 | null | Palliative (P) | 2017-12-28 | 2017-12-29 | LENALIDOMIDE | null | null | 290021435 | CAPECITABINE |
| 290006945 | 290005281 | 1.65 | 82.2 | Palliative (P) | 2014-01-11 | 2014-01-16 | MITOMYCIN | 2 | N | 290021439 | CAPECITABINE |
| 290006946 | 290005283 | null | 83 | Palliative (P) | 2015-08-16 | 2015-08-16 | OCTREOTIDE | 02 | N | 290021442 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 290006947 | 290005286 | 1.69 | null | Palliative (P) | 2015-03-21 | 2015-04-24 | PEMBROLIZUMAB | N | Y | 290021449 | CETUXIMAB |
| 290006948 | 290005287 | null | 62.4 | Neo-adjuvant (N) | null | 2016-11-28 | Carboplatin AUC 6 - 10 | N | null | 290021450 | CAPECITABINE + RT |
| 290006949 | 290005287 | null | null | Curative (C) | 2015-03-27 | 2016-02-17 | CETUXIMAB + RT | null | N | 290021450 | CAPECITABINE + OXALIPLATIN |
| 290006950 | 290005288 | null | 86 | Curative (C) | 2015-05-20 | 2015-06-20 | Capecitabine | 02 | N | 290021455 | FLUOROURACIL + MITOMYCIN |
| 290006951 | 290005288 | 1.65 | 60.3 | Palliative (P) | 2016-12-25 | 2016-12-25 | Sunitinib | 01 | N | 290021455 | CAPECITABINE + CISPLATIN |
| 290006952 | 290005288 | 1.55 | 76.2 | Curative (C) | 2013-06-08 | 2013-06-23 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 290021455 | CISPLATIN + RT |
| 290006953 | 290005289 | null | 67.6 | Adjuvant (A) | 2015-04-25 | 2016-01-15 | Capecitabine | null | N | 290021470 | CAPECITABINE + OXALIPLATIN |
| 290006954 | 290005290 | 1.71 | 77 | Palliative (P) | 2015-06-13 | 2015-06-20 | Hydroxycarbamide | 2 | N | 290021474 | MCX |
| 290006955 | 290005291 | 1.66 | 107.25 | Palliative (P) | 2014-11-09 | 2014-11-18 | Capecitabine + Oxaliplatin 14day | 02 | Y | 290021475 | CETUXIMAB + CISPLATIN + FU |
| 290006956 | 290005292 | null | null | Palliative (P) | 2014-06-06 | 2014-06-06 | TRASTUZUMAB | 2 | null | 290021476 | MCX |
| 290006957 | 290005293 | 1.69 | 83.6 | Palliative (P) | 2017-04-02 | 2017-04-26 | LANREOTIDE | N | N | 290021481 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 290006958 | 290005294 | null | 65.9 | Curative (C) | 2015-09-15 | 2015-10-07 | Cisplatin + Radiotherapy | 02 | N | 290021483 | CAPECITABINE + OXALIPLATIN |
| 290006959 | 290005295 | 1.4 | null | Curative (C) | 2017-11-14 | 2017-11-15 | Carbo F | N | N | 290021487 | CARBO + FLUOROURACIL |
| 290006960 | 290005296 | 1.65 | 72.8 | Adjuvant (A) | 2014-11-26 | 2014-12-25 | Capecitabine + Oxaliplatin 21day | 02 | N | 290021487 | CAPECITABINE |
| 290006961 | 290005296 | 1.7 | 58 | Adjuvant (A) | 2015-12-09 | 2015-12-28 | Cetuximab + Radiotherapy Load | 2 | N | 290021487 | CAPECITABINE + OXALIPLATIN |
| 290006962 | 290005296 | 1.75 | 0 | Disease modification (D) | 2015-02-11 | 2015-03-17 | Capecitabine | 02 | null | 290021487 | CARBOPLATIN |
| 290006963 | 290005297 | 1.7 | 53 | Palliative (P) | 2017-05-04 | 2017-05-21 | Cisplatin | N | N | 290021522 | IRINOTECAN |
| 290006964 | 290005300 | 1.56 | 44.3 | null | 2015-07-04 | 2015-07-19 | EOX | N | N | 290021522 | CARBOPLATIN |
| 290006965 | 290005302 | 1.74 | 81 | Palliative (P) | 2015-07-26 | 2015-07-26 | Capecitabine + Oxaliplatin 21day | 02 | Y | 290021531 | CAPECITABINE |
| 290006966 | 290005303 | 0 | 70.5 | Curative (C) | 2017-04-22 | 2017-11-12 | CISPLATIN + FLUOROURACIL + RT | N | N | 290021535 | CAPECITABINE + RT |
| 290006967 | 290005305 | 1.6 | 97 | Palliative (P) | 2016-07-02 | 2016-07-13 | DAIICHI Trial | 02 | N | 290021536 | CETUXIMAB |
| 290006968 | 290005305 | 1.73 | 48 | Palliative (P) | 2016-10-13 | 2017-01-30 | Capecitabine | null | null | 290021536 | LANREOTIDE |
| 290006969 | 290005306 | 1.82 | 57.65 | Adjuvant (A) | 2014-12-22 | 2016-11-02 | Docetaxel | null | null | 290021543 | CISPLATIN |
| 290006970 | 290005307 | 1.8 | null | Curative (C) | 2016-10-28 | 2016-11-10 | Capecitabine + Oxaliplatin 21day | 2 | N | 290021556 | CHOP R |
| 290006971 | 290005307 | 1.69 | null | Adjuvant (A) | 2017-08-12 | 2017-08-12 | CARBOPLATIN + ETOPOSIDE | N | null | 290021556 | SUNITINIB |
| 290006972 | 290005308 | 1.66 | 56.4 | Adjuvant (A) | 2017-04-17 | 2017-05-02 | LANREOTIDE | N | N | 290021568 | CAPECITABINE + OXALIPLATIN |
| 290006973 | 290005309 | 1.89 | 76.8 | Palliative (P) | 2010-03-19 | 2015-05-19 | CHOP R - 21 days | 2 | N | 290021569 | CAPECITABINE + CISPLATIN |
| 290006974 | 290005310 | 1.55 | 73.7 | Adjuvant (A) | 2018-11-02 | 2018-11-02 | CARBOPLATIN | N | Y | 290021576 | CAPECITABINE + OXALIPLATIN |
| 290006975 | 290005310 | 1.64 | 71.8 | 3 | 2014-12-29 | 2015-02-02 | LANREOTIDE | Y | N | 290021576 | FLUOROURACIL + MITOMYCIN |
| 290006976 | 290005311 | null | 75.5 | Palliative (P) | 2013-04-05 | 2013-05-09 | Trial Unspecified | N | N | 290021588 | CARBOPLATIN + PACLITAXEL |
| 290006977 | 290005312 | 1.68 | 50.4 | Not known (9) | 2015-06-23 | 2015-06-25 | Rituximab | 02 | Y | 290021589 | CAPECITABINE + OXALIPLATIN |
| 290006978 | 290005313 | 1.77 | 86 | Neo-adjuvant (N) | 2016-07-29 | 2016-07-29 | CAPECITABINE + OXALIPLATIN | 02 | N | 290021594 | CISPLATIN |
| 290006979 | 290005314 | 1.63 | 50.8 | Not known (9) | 2015-03-28 | 2015-04-22 | Panitumumab | N | null | 290021594 | CAPECITABINE + CARBOPLATIN |
| 290006980 | 290005319 | 1.56 | 67 | Adjuvant (A) | 2017-01-21 | 2017-01-24 | Trial Unspecified | 2 | N | 290021598 | CAPECITABINE + OXALIPLATIN |
| 290006981 | 290005320 | 1.6 | null | Adjuvant (A) | 2013-06-07 | 2013-06-21 | Cisplatin + Radiotherapy | N | N | 290021601 | CAPECITABINE |
| 290006982 | 290005321 | 1.65 | 72 | Disease modification (D) | 2016-06-22 | 2016-07-18 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 290021610 | CAPECITABINE + MITOMYCIN + RT |
| 290006983 | 290008297 | 0 | 71.9 | Palliative (P) | 2014-12-15 | 2016-02-14 | Capecitabine + Oxaliplatin 21day | N | N | 290021612 | CETUXIMAB + CISPLATIN + FU |
| 290006984 | 290005322 | 1.84 | 57.4 | Palliative (P) | 2015-12-09 | 2016-01-03 | Hydroxycarbamide | 02 | Y | 290021618 | OCTREOTIDE |